v3.26.1
Long-term Debt - Additional Information (Details) - USD ($)
3 Months Ended
Feb. 12, 2026
Mar. 31, 2026
Nov. 18, 2025
Debt Instrument [Line Items]      
Unamortized deferred financing costs   $ 4,300  
Unamortized original issue discount costs   12,000,000  
Amortization expense related to deferred financing costs and original issue discount.   400,000  
Credit Agreement | JPMorgan Chase Bank, N.A. | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Aggregate principal amount $ 1,525,000,000    
Credit Agreement | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan A Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Aggregate principal amount $ 750,000,000    
Line of credit facility maturity date Feb. 12, 2031    
Credit Agreement | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan B Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Aggregate principal amount $ 775,000,000    
Line of credit facility maturity date Aug. 12, 2031    
Credit Agreement | SOFR | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan A Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Interest rate added to base rate (as a percent) 2.75%    
Credit Agreement | SOFR | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan B Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Interest rate added to base rate (as a percent) 2.75%    
Credit Agreement | Alternate Base Rate | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan A Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Interest rate added to base rate (as a percent) 1.75%    
Credit Agreement | Alternate Base Rate | JPMorgan Chase Bank, N.A. | Senior Secured Term Loan B Facility | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Interest rate added to base rate (as a percent) 1.75%    
Bridge Term Loan Credit Agreement | JPMorgan Chase Bank, N.A. | Avadel Pharmaceuticals Plc      
Debt Instrument [Line Items]      
Aggregate principal amount     $ 1,500,000,000
Financing costs   $ 7,700,000